Clinical Trials for OBI Pharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: OBI Pharma

Clinical Trials (4)

A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

PHASE1/PHASE2Recruiting

111 participants

Started: Aug 4, 2025 · Completed: Feb 8, 2029

1 condition1 sponsor6 locations

A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors

PHASE1/PHASE2Active, not recruiting

117 participants

Started: Jun 12, 2024 · Completed: Jun 30, 2027

1 condition1 sponsor8 locations

To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer

PHASE2Recruiting

60 participants

Started: Jul 27, 2022 · Completed: May 31, 2026

1 condition1 sponsor7 locations

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

PHASE3Active, not recruiting

575 participants

Started: Dec 5, 2018 · Completed: Dec 30, 2027

1 condition1 sponsor128 locations